BounceBack capsules for reduction of DOMS after eccentric exercise: a randomized, double-blind, placebo-controlled,...

Area of Science:

• Exercise physiology
• Nutritional science
• Sports medicine

Background:

• Delayed onset muscle soreness (DOMS) is characterized by muscle pain and discomfort occurring 1-3 days post-exercise.
• DOMS is primarily attributed to microscopic muscle fiber tears, often resulting from eccentric exercise.
• This study investigated a dietary supplement's potential to mitigate DOMS.

Purpose of the Study:

• To evaluate the efficacy of a proprietary dietary supplement, BounceBack, in alleviating DOMS severity.
• To assess BounceBack's impact on pain, tenderness, and serological markers of inflammation and muscle damage.
• To determine the safety profile of BounceBack for managing exercise-induced muscle soreness.

Main Methods:

• A randomized, double-blind, placebo-controlled, crossover study design was employed.
• Ten healthy, untrained subjects aged 18-45 years participated.
• Inferential t-tests were used to analyze differences in outcome measures between groups at various time points.

Main Results:

• BounceBack intake for 30 days significantly reduced standardized measures of pain and tenderness post-eccentric exercise compared to placebo.
• Trends towards reduced plasma indicators of inflammation (hs-CRP) and muscle damage (CK, myoglobin) were observed.
• The supplement demonstrated a favorable safety profile in this pilot study.

Conclusions:

• BounceBack capsules significantly reduced pain and tenderness associated with DOMS following eccentric exercise.
• While not statistically significant, serological marker trends support the observed clinical benefits.
• Further research with larger sample sizes is recommended to confirm these findings and explore broader applications.